Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS SECRETARY BOWEN NOMINATES JOSEPH STETLER FOR RxPRC

Executive Summary

HHS SECRETARY BOWEN NOMINATES JOSEPH STETLER FOR RxPRC membership. Currently of counsel with D.C. law firm Hyman Phelps & McNamara, the former PMA president was named as a candidate for one of 11 positions on the Prescription Drug Payment Review Commission (RxPRC). Under the Catastrophic Care Act, enacted July 1, the commission will be appointed by the Office of Technology Assessment to monitor the financial health of the newly authorized Medicare drug program. OTA hopes to select the commission by November ("The Pink Sheet" Sept. 5, p. 3). Other nominees include American Health Care Registry President Judith Willis, who was nominated by HHS Undersecretary Don Newman. Raymond Gosselin, currently executive editor of the pharmacy magazine Pharmacy Times, was nominated by William Hassan, Jr., the chairman of the Board of Trustees of the Massachusetts College of Pharmacy and Allied Health Sciences. Gosselin is former president of the pharmacy school. OTA has received slightly more than 140 nominations. The agency expects the final tally of names to be around 160.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS014266

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel